Federal grants to Mapp Biopharmaceutical, Inc.
Mapp Biopharmaceutical, Inc. in San Diego, California received $4.1 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Allergy and Infectious Diseases Research, with $3.0 million. In fiscal 2025 it was awarded $1.2 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$4.1 million
- Awards4
- Awarded in FY 2025$1.2 million
- Largest award$1.8 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $1.4 million |
| FY 2022 | 2 | $1.3 million |
| FY 2023 | 0 | $0 |
| FY 2024 | 1 | $236,632 |
| FY 2025 | 2 | $1.2 million |
Programs that fund Mapp Biopharmaceutical, Inc.
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 3 | $3.0 million |
| Scientific Research - Combating Weapons of Mass Destruction | 1 | $1.1 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $3.0 million |
| Department of Defense | 1 | $1.1 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Development of highly potent human monoclonal for rsv immuno-prophylaxis | Allergy and Infectious Diseases Research | June 14, 2021 | $1.8 million |
| Fundamental research to counter weapons of mass destruction (c-wmd) | Scientific Research - Combating Weapons of Mass Destruction | March 1, 2021 | $1.1 million |
| Development of highly potent human monoclonal for rsv immunoprophylaxis - project summary globally, respiratory syncytial virus (RSV) causes over 3 million hospitalizations of neonates/infants. While there are licensed vaccines in the U.S. For use in elderly populations, they are neither approved no | Allergy and Infectious Diseases Research | September 24, 2025 | $993,353 |
| A novel cost-effective multispecific therapeutic for dengue - project summary dengue remains a major global health concern for which effective prophylactic and therapeutic options are urgently needed. The heightened dengue burden is driven by several factors including increased urbanization, world p | Allergy and Infectious Diseases Research | June 9, 2025 | $294,583 |
Questions people ask
How much federal grant money does Mapp Biopharmaceutical, Inc. get?
$4.1 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Mapp Biopharmaceutical, Inc. the most?
The Department of Health and Human Services, with $3.0 million in 3 awards. The Department of Defense follow.
What is Mapp Biopharmaceutical, Inc.'s largest federal grant?
$1.8 million under Allergy and Infectious Diseases Research, with its first action in the period on June 14, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Mapp Biopharmaceutical, Inc.?
Its largest are Allergy and Infectious Diseases Research and Scientific Research - Combating Weapons of Mass Destruction.
Other grant recipients in San Diego
- San Diego Association of Governments
- Metropolitan Transit System
- General Atomics
- Neighborhood House Association
- San Diego County Regional Airport Authority
- San Diego State University Foundation
- San Diego Unified School District
- Family Health Centers of San Diego Inc
Largest federal grant recipients in California · Federal grants in California